Review



recombinant proteins fluorescein 5 isothiocyanate fitc medchemexpress cas no 3326 32 7 c fos activator protein ap 1 inhibitor  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    MedChemExpress recombinant proteins fluorescein 5 isothiocyanate fitc medchemexpress cas no 3326 32 7 c fos activator protein ap 1 inhibitor
    Recombinant Proteins Fluorescein 5 Isothiocyanate Fitc Medchemexpress Cas No 3326 32 7 C Fos Activator Protein Ap 1 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 133 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+c+inhibitor/pm40848719-233-25-30?v=MedChemExpress
    Average 97 stars, based on 133 article reviews
    recombinant proteins fluorescein 5 isothiocyanate fitc medchemexpress cas no 3326 32 7 c fos activator protein ap 1 inhibitor - by Bioz Stars, 2026-08
    97/100 stars

    Images



    Similar Products

    97
    MedChemExpress recombinant proteins fluorescein 5 isothiocyanate fitc medchemexpress cas no 3326 32 7 c fos activator protein ap 1 inhibitor
    Recombinant Proteins Fluorescein 5 Isothiocyanate Fitc Medchemexpress Cas No 3326 32 7 C Fos Activator Protein Ap 1 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+c+inhibitor/pm40848719-233-25-30?v=MedChemExpress
    Average 97 stars, based on 1 article reviews
    recombinant proteins fluorescein 5 isothiocyanate fitc medchemexpress cas no 3326 32 7 c fos activator protein ap 1 inhibitor - by Bioz Stars, 2026-08
    97/100 stars
      Buy from Supplier

    93
    MedChemExpress recombinant protein c inhibitor
    Recombinant Protein C Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+c+inhibitor/pm38788977-63-38-43?v=MedChemExpress
    Average 93 stars, based on 1 article reviews
    recombinant protein c inhibitor - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    94
    R&D Systems c secretase inhibitor treatment recombinant human dll4
    C Secretase Inhibitor Treatment Recombinant Human Dll4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+c+inhibitor/pmc09549733__EMMM___14___e14526___s006-245-3-18?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    c secretase inhibitor treatment recombinant human dll4 - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    91
    R&D Systems granzyme b inhibitor bcl 2
    Granzyme B Inhibitor Bcl 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+c+inhibitor/10__1080_slash_2162402x__2020__1748991-61-4-10?v=R%26D+Systems
    Average 91 stars, based on 1 article reviews
    granzyme b inhibitor bcl 2 - by Bioz Stars, 2026-08
    91/100 stars
      Buy from Supplier

    86
    ProSci Incorporated recombinant human vegfc
    Figure 6 Effects of IFNTor IFNA on ISG15, <t>VEGFC,</t> and VEGFR3 mRNA expression in LyECs and LECs. IFNT stimulated mRNA expression of ISG15 and VEGFC but not VEGFR3 in LyECs (A–C). IFNT also stimulated ISG15 and VEGFC mRNA expression in LECs (D and E). In contrast, IFNA stimulated ISG15 mRNA expression (F) but tended to decrease VEGFC mRNA expression in LyECs (G). IFNA had no effect on VEGFR3 mRNA expression (H). In LECs, IFNA stimulated ISG15 mRNA expression but not VEGFC mRNA expression (I and J). White bars indicate the control group (no treatment), while black bars indicate 0.6–60 IU/ml IFNT-treated or IFNA-treated groups. All values are shown as meanGS.E.M. (nZ4/group). *Significant differences (P!0.05) and #tendency to difference (P!0.1) as determined by ANOVA followed by Fisher’s multiple comparison test.
    Recombinant Human Vegfc, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+c+inhibitor/10__1530_slash_rep___11___0157-146-37-43?v=ProSci+Incorporated
    Average 86 stars, based on 1 article reviews
    recombinant human vegfc - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human ifn c
    Figure 6 Effects of IFNTor IFNA on ISG15, <t>VEGFC,</t> and VEGFR3 mRNA expression in LyECs and LECs. IFNT stimulated mRNA expression of ISG15 and VEGFC but not VEGFR3 in LyECs (A–C). IFNT also stimulated ISG15 and VEGFC mRNA expression in LECs (D and E). In contrast, IFNA stimulated ISG15 mRNA expression (F) but tended to decrease VEGFC mRNA expression in LyECs (G). IFNA had no effect on VEGFR3 mRNA expression (H). In LECs, IFNA stimulated ISG15 mRNA expression but not VEGFC mRNA expression (I and J). White bars indicate the control group (no treatment), while black bars indicate 0.6–60 IU/ml IFNT-treated or IFNA-treated groups. All values are shown as meanGS.E.M. (nZ4/group). *Significant differences (P!0.05) and #tendency to difference (P!0.1) as determined by ANOVA followed by Fisher’s multiple comparison test.
    Recombinant Human Ifn C, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+protein+c+inhibitor/pm19508864-32-6-9?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    recombinant human ifn c - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    Image Search Results


    Figure 6 Effects of IFNTor IFNA on ISG15, VEGFC, and VEGFR3 mRNA expression in LyECs and LECs. IFNT stimulated mRNA expression of ISG15 and VEGFC but not VEGFR3 in LyECs (A–C). IFNT also stimulated ISG15 and VEGFC mRNA expression in LECs (D and E). In contrast, IFNA stimulated ISG15 mRNA expression (F) but tended to decrease VEGFC mRNA expression in LyECs (G). IFNA had no effect on VEGFR3 mRNA expression (H). In LECs, IFNA stimulated ISG15 mRNA expression but not VEGFC mRNA expression (I and J). White bars indicate the control group (no treatment), while black bars indicate 0.6–60 IU/ml IFNT-treated or IFNA-treated groups. All values are shown as meanGS.E.M. (nZ4/group). *Significant differences (P!0.05) and #tendency to difference (P!0.1) as determined by ANOVA followed by Fisher’s multiple comparison test.

    Journal: REPRODUCTION

    Article Title: Possible involvement of IFNT in lymphangiogenesis in the corpus luteum during the maternal recognition period in the cow

    doi: 10.1530/rep-11-0157

    Figure Lengend Snippet: Figure 6 Effects of IFNTor IFNA on ISG15, VEGFC, and VEGFR3 mRNA expression in LyECs and LECs. IFNT stimulated mRNA expression of ISG15 and VEGFC but not VEGFR3 in LyECs (A–C). IFNT also stimulated ISG15 and VEGFC mRNA expression in LECs (D and E). In contrast, IFNA stimulated ISG15 mRNA expression (F) but tended to decrease VEGFC mRNA expression in LyECs (G). IFNA had no effect on VEGFR3 mRNA expression (H). In LECs, IFNA stimulated ISG15 mRNA expression but not VEGFC mRNA expression (I and J). White bars indicate the control group (no treatment), while black bars indicate 0.6–60 IU/ml IFNT-treated or IFNA-treated groups. All values are shown as meanGS.E.M. (nZ4/group). *Significant differences (P!0.05) and #tendency to difference (P!0.1) as determined by ANOVA followed by Fisher’s multiple comparison test.

    Article Snippet: Inc. (Otsu, Japan); 4% Block Ace Powder was purchased from DS Pharma Biomedical (Osaka, Japan); anti-mouse-LYVE1 rabbit polyclonal antibody was purchased from Abcam (Cambridge, UK); BD Matrigel basement membrane was purchased from BD Biosciences (Bedford, MA, USA); recombinant human VEGFC was purchased from ProSci (Poway, CA, USA); protease inhibitor cocktail was purchased from Roche; 70 mm filter (Cell Straner, REF 352350) was purchased from BD Falcon (Franklin Lakes, NJ, USA); PVDF membranes were purchased from Bio-Rad Laboratories; lymphoprep was purchased from AxisShield (Oslo, Norway); HRP-conjugated anti-rabbit IgG antibodies were purchased from GE Healthcare Ltd (Chalfont St Giles, UK); HRP-conjugated anti-mouse IgG antibodies were purchased from Rockland Immunochemicals, Inc. (Gilbertsville, PA, USA); anti-human VWF rabbit polyclonal antibody (clone A0082) was purchased from Dako Denmark A/S (Glostrup, Denmark); biotinylated goat anti-rabbit BA-1000 IgG and avidin–biotin reagent (PK-6100, Vectastain ABC kit) were purchased from Vector Laboratories, Inc. (Burlingame, CA, USA); recombinant bovine IFN was produced by Escherichia coli.

    Techniques: Expressing, Control, Comparison

    Figure 7 Effects of IFNT on proliferation of LyECs and capillary-like tube formation. IFNT stimulated the proliferation of LyECs (A) and promoted the capillary-like tube formation of LyECs as well as 100 ng/ml VEGFC (B). Panels C, D and E show typical images of capillary-like tube formation in matrigel assays on LyECs. All values are shown as meanGS.E.M. (nZ4/group). The scale bars rep- resent 500 mm. *, **Significant differences (P!0.05 or P!0.01) and #tendency to difference (P!0.1) as determined by ANOVA followed by Fisher’s multiple comparison test.

    Journal: REPRODUCTION

    Article Title: Possible involvement of IFNT in lymphangiogenesis in the corpus luteum during the maternal recognition period in the cow

    doi: 10.1530/rep-11-0157

    Figure Lengend Snippet: Figure 7 Effects of IFNT on proliferation of LyECs and capillary-like tube formation. IFNT stimulated the proliferation of LyECs (A) and promoted the capillary-like tube formation of LyECs as well as 100 ng/ml VEGFC (B). Panels C, D and E show typical images of capillary-like tube formation in matrigel assays on LyECs. All values are shown as meanGS.E.M. (nZ4/group). The scale bars rep- resent 500 mm. *, **Significant differences (P!0.05 or P!0.01) and #tendency to difference (P!0.1) as determined by ANOVA followed by Fisher’s multiple comparison test.

    Article Snippet: Inc. (Otsu, Japan); 4% Block Ace Powder was purchased from DS Pharma Biomedical (Osaka, Japan); anti-mouse-LYVE1 rabbit polyclonal antibody was purchased from Abcam (Cambridge, UK); BD Matrigel basement membrane was purchased from BD Biosciences (Bedford, MA, USA); recombinant human VEGFC was purchased from ProSci (Poway, CA, USA); protease inhibitor cocktail was purchased from Roche; 70 mm filter (Cell Straner, REF 352350) was purchased from BD Falcon (Franklin Lakes, NJ, USA); PVDF membranes were purchased from Bio-Rad Laboratories; lymphoprep was purchased from AxisShield (Oslo, Norway); HRP-conjugated anti-rabbit IgG antibodies were purchased from GE Healthcare Ltd (Chalfont St Giles, UK); HRP-conjugated anti-mouse IgG antibodies were purchased from Rockland Immunochemicals, Inc. (Gilbertsville, PA, USA); anti-human VWF rabbit polyclonal antibody (clone A0082) was purchased from Dako Denmark A/S (Glostrup, Denmark); biotinylated goat anti-rabbit BA-1000 IgG and avidin–biotin reagent (PK-6100, Vectastain ABC kit) were purchased from Vector Laboratories, Inc. (Burlingame, CA, USA); recombinant bovine IFN was produced by Escherichia coli.

    Techniques: Comparison